Elevated levels of amyloid precursor protein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease defined by motor neuron loss. Transgenic mouse models show features that closely mimic those seen in the clinical situation, reflected in the molecular changes observed in mouse models and in tissues from patients. We report a dramatic increase in the expression of amyloid precursor protein (APP) in the hindlimb muscles, but not the spinal cord of the G93A transgenic mouse model, significantly before the appearance of clinical abnormalities. APP levels were unchanged in nontransgenic mice and in mice overexpressing human wild‐type Cu/Zn‐dependent superoxide dismutase 1 (SOD1). Preliminary results indicate a similar change in APP expression in human deltoid muscle samples from ALS patients compared with age‐matched controls. The inhibitory role of APP in innervation at the neuromuscular junction and increased expression in inclusion‐body myositis suggest that presymptomatic upregulation of APP may be consistent with a potential role for APP in ALS pathology. Muscle Nerve, 2006

[1]  V. Meininger,et al.  Nogo Provides a Molecular Marker for Diagnosis of Amyotrophic Lateral Sclerosis , 2002, Neurobiology of Disease.

[2]  M. Beal,et al.  Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.

[3]  C. Masters,et al.  Survival of Cultured Neurons from Amyloid Precursor Protein Knock-Out Mice against Alzheimer’s Amyloid-β Toxicity and Oxidative Stress , 1998, The Journal of Neuroscience.

[4]  D. Riddell,et al.  Characterization of the Ectodomain Shedding of the β-Site Amyloid Precursor Protein-cleaving Enzyme 1 (BACE1)* , 2003, Journal of Biological Chemistry.

[5]  C. Masters,et al.  Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons. , 1994, The Journal of biological chemistry.

[6]  J. Holstege,et al.  Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression in Mice Causes Mitochondrial Vacuolization, Axonal Degeneration, and Premature Motoneuron Death and Accelerates Motoneuron Disease in Mice Expressing a Familial Amyotrophic Lateral Sclerosis Mutant SOD1 , 2000, Neurobiology of Disease.

[7]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[8]  J. Buxbaum,et al.  Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis , 2001, The Lancet.

[9]  M. Gurney,et al.  Age-Dependent Penetrance of Disease in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1995, Molecular and Cellular Neuroscience.

[10]  W. Gan,et al.  Defective Neuromuscular Synapses in Mice Lacking Amyloid Precursor Protein (APP) and APP-Like Protein 2 , 2005, The Journal of Neuroscience.

[11]  M. Pangalos,et al.  The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models , 2000, Journal of Neuroscience Methods.

[12]  P. Caroni,et al.  Accumulation of SOD1 Mutants in Postnatal Motoneurons Does Not Cause Motoneuron Pathology or Motoneuron Disease , 2002, The Journal of Neuroscience.

[13]  P. Caroni,et al.  Early and Selective Loss of Neuromuscular Synapse Subtypes with Low Sprouting Competence in Motoneuron Diseases , 2000, The Journal of Neuroscience.

[14]  M. Gurney,et al.  The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[16]  L. Bruijn,et al.  Unraveling the mechanisms involved in motor neuron degeneration in ALS. , 2004, Annual review of neuroscience.

[17]  Julio C. Echegoyen,et al.  Inclusion body myositis-like phenotype induced by transgenic overexpression of βAPP in skeletal muscle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Masters,et al.  Processing of the Alzheimer's disease amyloid precursor protein in Pichia pastoris: immunodetection of alpha-, beta-, and gamma-secretase products. , 1998, Biochemistry.

[19]  T. Tabira,et al.  Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production , 2001, Neuroscience Letters.

[20]  Steven A. Johnson,et al.  Expression of β-Amyloid Precursor Protein Gene Is Developmentally Regulated in Human Muscle Fibers in Vivo and in Vitro , 1994, Experimental Neurology.

[21]  M. Gurney,et al.  Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS) , 1995, Brain Research.

[22]  W. Engel,et al.  Impaired innervation of cultured human muscle overexpressing βAPP experimentally and genetically: relevance to inclusion‐body myopathies , 1998, Neuroreport.

[23]  W. Engel,et al.  Strong immunoreactivity of β-amyloid precursor protein, including the β-amyloid protein sequence, at human neuromuscular junctions , 1992, Neuroscience Letters.

[24]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[25]  D. Winge,et al.  A method for distinguishing Cu,Zn- and Mn-containing superoxide dismutases. , 1983, Analytical biochemistry.

[26]  T. Ishii,et al.  Ultrastructural and histochemical study of the motor end plates of the intrinsic laryngeal muscles in amyotrophic lateral sclerosis. , 1998, Ultrastructural pathology.

[27]  M. Wolfe,et al.  A Portrait of Alzheimer Secretases--New Features and Familiar Faces , 2001, Science.

[28]  V. Sée,et al.  Amyloid Precursor Protein Family-induced Neuronal Death Is Mediated by Impairment of the Neuroprotective Calcium/Calmodulin Protein Kinase IV-dependent Signaling Pathway* , 2002, The Journal of Biological Chemistry.

[29]  H. Cai,et al.  Genetically engineered mouse models of neurodegenerative diseases , 2002, Nature Neuroscience.

[30]  J. Glass,et al.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man , 2004, Experimental Neurology.

[31]  M. Gurney,et al.  Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Borchelt,et al.  Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. , 1999, Human molecular genetics.

[33]  B. Greenberg,et al.  Neurotrophic regulation of mouse muscle β‐amyloid protein precursor and α1‐antichymotrypsin as revealed by axotomy , 1994 .

[34]  W. Engel,et al.  Newest pathogenetic considerations in inclusion-body myositis: Possible role amyloid-β, cholesterol, relation to aging and to alzheimer’s disease , 2002, Current rheumatology reports.

[35]  W. Snider,et al.  Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration , 2000, The Journal of Neuroscience.